Procter & Gamble (P&G) reported its fiscal year 2025 first quarter results, revealing sluggish sales growth primarily due to weak demand in key markets such as the U.S. and China. The company's quarterly sales slipped, missing analysts' estimates, despite earnings beating expectations with an EPS of $1.90. P&G's sales growth was driven by minimal price increases and weakness in key areas like skin and baby care. The company reported a 2% increase in sales, but premium beauty products, particularly SK-II, faced significant inventory and demand hits in China. P&G's CFO indicated that the Chinese market is expected to remain weak for several quarters. Despite these challenges, P&G maintained its outlook for organic sales growth in the range of three to five percent. Pricing increased by 1%, volume remained flat, and $PG was down 1.3% pre-market.